Chen Fang BS, MEng, PhD

Chen Fang, PhD is a Senior Scientist, Bioconjugation Development at Goodwin Biotechnology, where he performs proof-of-concept, process development, and manufacturing of bioconjugation and protein modification processes. Dr. Fang completed his BS in Materials Science and Engineering in 2001 at Shanghai Jiao Tong University, where he went on to complete his MS degree in Materials Science. From there, Dr. Fang attended the University of Washington where he completed his PhD in Materials Science and Engineering. As a post-doc, Dr. Fang worked at the Oliver Press Lab at the Fred Hutchinson Cancer Research Center, where he refined his expertise in the synthesis characterization and pre-clinical evaluation of antibodies, antibody-drug conjugates, radio-immuno-conjugates, bispecific antibodies, and nanoparticles.